Myocardial perfusion scintigraphy in acute myocardial infarction patients treated with successful percutaneous coronary intervention

Myocardial perfusion scintigraphy in acute myocardial infarction patients treated with successful percutaneous coronary intervention - Myocardial perfusion scintigraphy in acute myocardial infarction patients treated with successful percutaneous coronary intervention

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002798

Enrollment

100

Registered

2009-11-25

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with acute myocardial infarction confirmed by coronary angiography and those who were successfully treated with PCI in the acute phase were enrolled.

Exclusion criteria

Exclusion criteria: Patients who had acute coronary syndrome within the last half year, those with severe hepatic and/or renal impairment, those with inappropriate arrhythmia, such as premature ventricular contraction (PVC) and atrial fibrillation, for electrocardiography-gated SPECT data collection, and small heart patients.

Design outcomes

Primary

Measure	Time frame
1.Hematological evaluation Creatinine kinase (CK), CK-myoglobin binding (CK-MB), brain natriuretic peptide (BNP), creatinine (Cr) 2.Myocardial planner images Planner images obtained in the early and delayed phase after tracer injection 3.Myocardial single photon emission computed tomography (SPECT) Short-axis SPECT images at rest 4.Gated SPECT Left ventricular (LV) end systolic and diastolic volumes, LV ejection fraction, LV diastolic function	—

Measure

Time frame

1.Hematological evaluation Creatinine kinase (CK), CK-myoglobin binding (CK-MB), brain natriuretic peptide (BNP), creatinine (Cr) 2.Myocardial planner images Planner images obtained in the early and delayed phase after tracer injection 3.Myocardial single photon emission computed tomography (SPECT) Short-axis SPECT images at rest 4.Gated SPECT Left ventricular (LV) end systolic and diastolic volumes, LV ejection fraction, LV diastolic function

—

Secondary

Measure	Time frame
1.Planner images in the lower extremities (using 99mTc-MIBI) Images in the upper and lower thighs obtained at the early phase after tracer injection 2.Cardiopulmonary exercise testing Systolic and diastolic blood pressures at rest, at warming up, during exercise, at peak exercise and cooling down, pulse, a respiratory rates (RR), minute ventilation (VE), oxygen uptake (VO2), a carbon dioxide production rate (VCO2), the relation between ventilation and VO2 (VE/ VO2), the relation between ventilation and VCO2 (VE/VCO2), anaerobic threshold (AT), peak VO2, VE/VCO2 slope, VO2/WR, end-tidal oxygen tension pressure (PETO2), end-tidal carbon dioxide pressure (PETCO2)	—

Measure

Time frame

1.Planner images in the lower extremities (using 99mTc-MIBI) Images in the upper and lower thighs obtained at the early phase after tracer injection 2.Cardiopulmonary exercise testing Systolic and diastolic blood pressures at rest, at warming up, during exercise, at peak exercise and cooling down, pulse, a respiratory rates (RR), minute ventilation (VE), oxygen uptake (VO2), a carbon dioxide production rate (VCO2), the relation between ventilation and VO2 (VE/ VO2), the relation between ventilation and VCO2 (VE/VCO2), anaerobic threshold (AT), peak VO2, VE/VCO2 slope, VO2/WR, end-tidal oxygen tension pressure (PETO2), end-tidal carbon dioxide pressure (PETCO2)

—

Countries

Japan

Contacts

Public ContactKohei Ashikaga

St.Marianna Uneversity School of Medicine Division of cardiology,Department of Internal Medicine

k2ashikaga@marianna-u.ac.jp044-977-8111

Outcome results